Contains observed concentrations of cytokines and their respective treatment and groups, derived from:
Format
A data frame with 297 rows and 29 columns:
- Group
Group assigned to the subjects.
- Treatment
Treatment received by subjects.
- Time
Time point of the measurement.
- IL-17F
Observed concentration of IL-17F cytokine.
- GM-CSF
Observed concentration of GM-CSF cytokine.
- IFN-G
Observed concentration of IFN-G cytokine.
- IL-10
Observed concentration of IL-10 cytokine.
- CCL-20/MIP-3A
Observed concentration of CCL-20/MIP-3A cytokine.
- IL-12/P70
Observed concentration of IL-12/P70 cytokine.
- IL-13
Observed concentration of IL-13 cytokine.
- IL-15
Observed concentration of IL-15 cytokine.
- IL-17A
Observed concentration of IL-17A cytokine.
- IL-22
Observed concentration of IL-22 cytokine.
- IL-9
Observed concentration of IL-9 cytokine.
- IL-1B
Observed concentration of IL-1B cytokine.
- IL-33
Observed concentration of IL-33 cytokine.
- IL-2
Observed concentration of IL-2 cytokine.
- IL-21
Observed concentration of IL-21 cytokine.
- IL-4
Observed concentration of IL-4 cytokine.
- IL-23
Observed concentration of IL-23 cytokine.
- IL-5
Observed concentration of IL-5 cytokine.
- IL-6
Observed concentration of IL-6 cytokine.
- IL-17E/IL-25
Observed concentration of IL-17E/IL-25 cytokine.
- IL-27
Observed concentration of IL-27 cytokine.
- IL-31
Observed concentration of IL-31 cytokine.
- TNF-A
Observed concentration of TNF-A cytokine.
- TNF-B
Observed concentration of TNF-B cytokine.
- IL-28A
Observed concentration of IL-28A cytokine.
References
Pugh GH, Fouladvand S, SantaCruz-Calvo S, Agrawal M, Zhang XD, Chen J, Kern PA, Nikolajczyk BS. T cells dominate peripheral inflammation in a cross-sectional analysis of obesity-associated diabetes. Obesity (Silver Spring). 2022;30(10): 1983–1994. doi:10.1002/oby.23528.
Examples
data(ExampleData1)